Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

Prospective Registry The Treatment Of Upper And Lower Intestinal Anastomotic Leaks And Perforations

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02477930

Enrollment

Registered

2015-06-23

Start date

2014-11-01

Completion date

2023-09-21

Last updated

2025-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intestinal Anastomotic Leak, Intestinal Perforations

Brief summary

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Interventions

OTHERNo interventions are done

No intervention is done. This is a registry study.

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients undergoing E-Vac Therapy * Age \> 17 years

Exclusion criteria

* 17 years of age or younger * Undergone an E-Vac placement \> 14 days before consenting

Design outcomes

Primary

Measure	Time frame
In-Hospital survival-rate	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026